Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post COVID-19 Pneumo-hematocele: Clinical Presentation and Treatment Pathway

NCT05067881 is registered in ClinicalTrials.gov with Hospital General Ajusco Medio as lead sponsor.

NCT NCT05067881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05067881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post COVID-19 Pneumo-hematocele: Clinical Presentation and Treatment Pathway
Lead sponsor
Hospital General Ajusco Medio
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
September 20, 2021
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 respiratory infection